OPINION
Published on 04 Jan 2023
Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma
doi 10.3389/fonc.2022.1098375
- 9,688 views
- 2 citations
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Point and Counterpoint - The Trainees' Corner
Point and Counterpoint - The Trainees' Corner
3,917
Total downloads
16k
Total views and downloads
Articles
OPINION
Published on 08 Sep 2021
Debating Frontline Therapy in Chronic Myeloid Leukemia
doi 10.3389/fonc.2021.708823
- 2,311 views
- 1 citation
OPINION
Published on 04 Jun 2021
Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?
doi 10.3389/fonc.2021.686223
- 6,926 views
- 1 citation
OPINION
Published on 22 Dec 2020
Upfront Treatment of FLT3-Mutated AML: A Look Back at the RATIFY Trial and Beyond
doi 10.3389/fonc.2020.562219
- 4,639 views
- 7 citations
OPINION
Published on 22 Oct 2020
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
doi 10.3389/fonc.2020.576924
- 2,239 views
- 2 citations
